Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis.

Howard JF. et al, (2021), Expert Opin Investig Drugs, 1 - 11

Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.

Binks SNM. et al, (2021), JAMA Neurol

Pregnancy in Patients With AQP4-Ab, MOG-Ab or Double-Negative Neuromyelitis Optica Disorder.

Collongues N. et al, (2021), Neurology

Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.

Mariano R. et al, (2021), Brain, 144, 198 - 212

Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.

Leite MI., (2021), Neurology, 96, 294 - 295

Foveal changes in AQP4-Ab seropositive NMOSD are independent of optic neuritis and not overtly progressive.

Roca-Fernández A. et al, (2021), Eur J Neurol

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.

Messina S. et al, (2021), Mult Scler Relat Disord, 49

Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).

Specovius S. et al, (2020), BMJ Open, 10

A challenging case of hypercapnic respiratory failure during pregnancy

Vijayakumar B. et al, (2020), Obstetric Medicine, 1753495X2094470 - 1753495X2094470

A clinico-neurophysiological study of urogenital dysfunction in MOG-antibody transverse myelitis.

Li V. et al, (2020), Neurology

Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease.

Dos Passos GR. et al, (2020), J Neurol Sci, 415

State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis.

Sá MJ. et al, (2020), Neurol Ther

Treatment of MOG antibody associated disorders: results of an international survey.

Whittam DH. et al, (2020), J Neurol

Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK.

O'Connell K. et al, (2020), J Neurol Neurosurg Psychiatry

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.

Whittam DH. et al, (2020), Mult Scler Relat Disord, 44

Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms

Ramberger M. et al, (2020), Brain, 143, 1731 - 1745

Prodromal headache in MOG-antibody positive optic neuritis.

Asseyer S. et al, (2020), Mult Scler Relat Disord, 40

Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes.

Tsymala I. et al, (2020), Acta Neuropathol Commun, 8

International multicenter examination of MOG antibody assays

Reindl M. et al, (2020), Neurology - Neuroimmunology Neuroinflammation, 7, e674 - e674

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies.

Yeo T. et al, (2020), Ann Clin Transl Neurol, 7, 375 - 383

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?